Articles with public access mandates - John TrachtenbergLearn more
Not available anywhere: 6
Exploring gay couples’ experience with sexual dysfunction after radical prostatectomy: a qualitative study
ME Hartman, J Irvine, KL Currie, P Ritvo, L Trachtenberg, A Louis, ...
Journal of sex & marital therapy 40 (3), 233-253, 2014
Mandates: Canadian Institutes of Health Research
A system for MRI‐guided transperineal delivery of needles to the prostate for focal therapy
J Cepek, BA Chronik, U Lindner, J Trachtenberg, SRH Davidson, J Bax, ...
Medical physics 40 (1), 012304, 2013
Mandates: Canadian Institutes of Health Research
Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer
LM Wong, DE Neal, A Finelli, S Davis, C Bonner, J Kapoor, ...
Prostate Cancer and Prostatic Diseases 18 (2), 137-143, 2015
Mandates: Cancer Research UK, National Institute for Health Research, UK
MRI-guided prostate focal laser ablation therapy using a mechatronic needle guidance system
J Cepek, U Lindner, S Ghai, SRH Davidson, J Trachtenberg, A Fenster
Medical Imaging 2014: Image-Guided Procedures, Robotic Interventions, and …, 2014
Mandates: Ontario Institute for Cancer Research
Update in Interventional Oncology: Session 2-Advances in Treatment-Prostate and Liver
A Goldenberg, J Trachtenberg, M Sussman, Y Yi, U Lindner, L Ma, ...
Int J CARS 5 (1), S23-S27, 2010
Mandates: US National Institutes of Health
2009 CUA Abstracts
F Bénard, R Casey, S Carrier, J Lee, V Talwar, I Defoy, T Domes, ...
Canadian Urological Association Journal= Journal de L'association des …, 2009
Mandates: Canadian Institutes of Health Research
Available somewhere: 31
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy
RK Nam, R Saskin, Y Lee, Y Liu, C Law, LH Klotz, DA Loblaw, ...
The Journal of urology 183 (3), 963-969, 2010
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
The role of focal therapy in the management of localised prostate cancer: a systematic review
M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ...
European urology 66 (4), 732-751, 2014
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Vascular‐targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses
J Trachtenberg, RA Weersink, SRH Davidson, MA Haider, A Bogaards, ...
BJU international 102 (5), 556-562, 2008
Mandates: US National Institutes of Health
Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer
SRH Davidson, RA Weersink, MA Haider, MR Gertner, A Bogaards, ...
Physics in Medicine & Biology 54 (8), 2293, 2009
Mandates: US National Institutes of Health
Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort
B Bhindi, J Locke, SMH Alibhai, GS Kulkarni, DS Margel, RJ Hamilton, ...
European urology 67 (1), 64-70, 2015
Mandates: Canadian Cancer Society, Prostate Cancer Canada
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST 11‐vascular‐targeted photodynamic …
CM Moore, AR Azzouzi, E Barret, A Villers, GH Muir, NJ Barber, S Bott, ...
BJU international 116 (6), 888-896, 2015
Mandates: National Institute for Health Research, UK, Prostate Cancer UK, Wellcome Trust
The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer
MR Akbari, CJD Wallis, A Toi, J Trachtenberg, P Sun, SA Narod, RK Nam
British journal of cancer 111 (6), 1238-1240, 2014
Mandates: Canadian Institutes of Health Research
Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer
MR Akbari, J Trachtenberg, J Lee, S Tam, R Bristow, A Loblaw, SA Narod, ...
Journal of the National Cancer Institute 104 (16), 1260-1262, 2012
Mandates: Canadian Institutes of Health Research, Genome Canada
Utility of incorporating genetic variants for the early detection of prostate cancer
RK Nam, WW Zhang, J Trachtenberg, A Seth, LH Klotz, A Stanimirovic, ...
Clinical Cancer Research 15 (5), 1787-1793, 2009
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer
SS Sridhar, SJ Hotte, JL Chin, GR Hudes, R Gregg, J Trachtenberg, ...
American journal of clinical oncology 33 (6), 609-613, 2010
Mandates: US National Institutes of Health
Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly
B Bhindi, GS Kulkarni, A Finelli, SMH Alibhai, RJ Hamilton, A Toi, ...
European urology 66 (5), 841-848, 2014
Mandates: Canadian Cancer Society, Prostate Cancer Canada
Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer
K Kron, L Liu, D Trudel, V Pethe, J Trachtenberg, N Fleshner, B Bapat, ...
Clinical cancer research 18 (10), 2896-2904, 2012
Mandates: Canadian Institutes of Health Research
Prehabilitation for men undergoing radical prostatectomy: a multi-centre, pilot randomized controlled trial
D Santa Mina, AG Matthew, WJ Hilton, D Au, R Awasthi, SMH Alibhai, ...
BMC surgery 14, 1-8, 2014
Mandates: Prostate Cancer Canada
A pilot randomized trial of conventional versus advanced pelvic floor exercises to treat urinary incontinence after radical prostatectomy: a study protocol
D Santa Mina, D Au, SMH Alibhai, L Jamnicky, N Faghani, WJ Hilton, ...
BMC urology 15, 1-10, 2015
Mandates: Prostate Cancer Canada
Publication and funding information is determined automatically by a computer program